Chu W - Search Results

1

Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.

Nam RK, Elhaji Y, Krahn MD, Hakimi J, Ho M, Chu W, Sweet J, Trachtenberg J, Jewett MA, Narod SA. Nam RK, et al. Among authors: chu w. J Urol. 2000 Aug;164(2):567-72. J Urol. 2000. PMID: 10893645

2

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.

Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA. Moslehi R, et al. Among authors: chu w. Am J Hum Genet. 2000 Apr;66(4):1259-72. doi: 10.1086/302853. Epub 2000 Mar 16. Am J Hum Genet. 2000. PMID: 10739756 Free PMC article.

3

Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?

Goshen R, Chu W, Elit L, Pal T, Hakimi J, Ackerman I, Fyles A, Mitchell M, Narod SA. Goshen R, et al. Among authors: chu w. Gynecol Oncol. 2000 Dec;79(3):477-81. doi: 10.1006/gyno.2000.6003. Gynecol Oncol. 2000. PMID: 11104623

4

Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.

Jernström H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, Pollak M, Narod SA. Jernström H, et al. Among authors: chu w. Mol Genet Metab. 2001 Feb;72(2):144-54. doi: 10.1006/mgme.2000.3130. Mol Genet Metab. 2001. PMID: 11161840

5

V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression.

Nam RK, Toi A, Vesprini D, Ho M, Chu W, Harvie S, Sweet J, Trachtenberg J, Jewett MA, Narod SA. Nam RK, et al. Among authors: chu w. Urology. 2001 Jan;57(1):199-204. doi: 10.1016/s0090-4295(00)00928-6. Urology. 2001. PMID: 11164181

6

Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.

Jernström H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M. Jernström H, et al. Among authors: chu w. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):377-84. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11319179

7

CYP gene polymorphisms and early menarche.

Lai J, Vesprini D, Chu W, Jernström H, Narod SA. Lai J, et al. Among authors: chu w. Mol Genet Metab. 2001 Dec;74(4):449-57. doi: 10.1006/mgme.2001.3260. Mol Genet Metab. 2001. PMID: 11749050

8

Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.

Nam RK, Zhang WW, Trachtenberg J, Jewett MA, Emami M, Vesprini D, Chu W, Ho M, Sweet J, Evans A, Toi A, Pollak M, Narod SA. Nam RK, et al. Among authors: chu w. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1429-37. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693733 Clinical Trial.

9

Breast tissue organochlorine levels and metabolic genotypes in relation to breast cancer risk Canada.

McCready D, Aronson KJ, Chu W, Fan W, Vesprini D, Narod SA. McCready D, et al. Among authors: chu w. Cancer Causes Control. 2004 May;15(4):399-418. doi: 10.1023/B:CACO.0000027505.32564.c2. Cancer Causes Control. 2004. PMID: 15141140

10

Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use.

Chu W, Fyles A, Sellers EM, McCready DR, Murphy J, Pal T, Narod SA. Chu W, et al. Carcinogenesis. 2007 Oct;28(10):2139-42. doi: 10.1093/carcin/bgm087. Epub 2007 Apr 13. Carcinogenesis. 2007. PMID: 17434921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,254 results

Search Page

Filters